Biden’s Big Chance to Lower Drug Prices

A decision on whether to open a costly cancer drug to generic competition will be made shortly. It doesn’t require congressional approval.

by

TAP depends on your support

We’ve said it before: The greatest threat to democracy from the media isn’t disinformation, it’s the paywall. When you support The American Prospect, you’re supporting fellow readers who aren’t able to give, and countering the class system for information. Please, become a member, or make a one-time donation, today. Thank you!